Thereby, higher baseline AQP4 levels might be protective against a stroke, indicating that this protein could independently predict good neurological outcomes and be used as a biomarker of neurological recovery in the acute-subacute phase of a stroke [31]. This evidence concerns the gene AQP4 and stroke disorder.